Article
Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese patient with lipoprotein glomerulopathy.
Kidney & blood pressure research - 1 Jan 2014
Li Wencheng, Wang Yang, Han Zhiwu, Luo Changqing, Zhang Chun, Xiong Jing
Abstract excerpt
BACKGROUND/AIMS: Lipoprotein glomerulopathy (LPG) is a rare hereditary disease. In this study, we investigated the apoE mutation and the role of double filtration plasmapheresis therapy (DFPP) on a new Chinese patient with LPG. METHODS: Renal biopsy was performed on this patient to allow a definitive diagnosis. The mutations in the coding sequence of apoE and the hereditary pedigree of this patient were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.